Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China
· Delayed Price · Currency is CNY 14.44
+0.20 (1.40%)
Apr 29, 2026, 3:04 PM CST
SHE:300003 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 830.28 | 962.01 | 246.94 | 1,258 | 2,204 | 1,719 | Upgrade
|
| Depreciation & Amortization | 638.8 | 638.8 | 560.04 | 513.56 | 488.47 | 448.74 | Upgrade
|
| Other Amortization | 83.46 | 83.46 | 96.42 | 90.22 | 79.16 | 72.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.87 | -4.87 | -11.73 | 7.87 | 1.69 | -19.9 | Upgrade
|
| Asset Writedown & Restructuring Costs | 43.83 | 43.83 | 134.76 | 36.59 | - | 2.39 | Upgrade
|
| Loss (Gain) From Sale of Investments | -54.2 | -54.2 | 89.29 | 13.44 | 70.91 | 367.54 | Upgrade
|
| Provision & Write-off of Bad Debts | 38.87 | 38.87 | 50.36 | 26.13 | 24.45 | 20.76 | Upgrade
|
| Other Operating Activities | 357.27 | 369.67 | 284.62 | 337.04 | 278.83 | 308.15 | Upgrade
|
| Change in Accounts Receivable | -489.63 | -489.63 | -62.84 | 3.22 | -665.07 | 42.85 | Upgrade
|
| Change in Inventory | -198.73 | -198.73 | 206.28 | -251.01 | -386.7 | -494.73 | Upgrade
|
| Change in Accounts Payable | 168.11 | 168.11 | -688.65 | -982 | 710.12 | 660.39 | Upgrade
|
| Operating Cash Flow | 1,373 | 1,517 | 734.64 | 990.36 | 2,791 | 3,062 | Upgrade
|
| Operating Cash Flow Growth | 35.63% | 106.48% | -25.82% | -64.51% | -8.86% | 46.53% | Upgrade
|
| Capital Expenditures | -760.19 | -643.06 | -658.82 | -844.67 | -905.22 | -984.4 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.73 | 1.62 | 30.03 | 8.52 | 2.55 | 2.09 | Upgrade
|
| Cash Acquisitions | - | - | -21.82 | -344.92 | -3.1 | -453.01 | Upgrade
|
| Divestitures | -14.45 | -13.95 | 4.42 | -48.08 | - | 0.15 | Upgrade
|
| Investment in Securities | 160.44 | -352.93 | -237.88 | -65.41 | -648.89 | 129.18 | Upgrade
|
| Other Investing Activities | 206.01 | 182.4 | 73.66 | -428.32 | 0.47 | 533.27 | Upgrade
|
| Investing Cash Flow | -271.29 | -690.74 | -743.9 | -1,886 | -1,599 | -860.46 | Upgrade
|
| Long-Term Debt Issued | - | 3,151 | 3,168 | 2,694 | 1,828 | 3,745 | Upgrade
|
| Long-Term Debt Repaid | - | -2,580 | -2,352 | -2,320 | -2,601 | -4,338 | Upgrade
|
| Total Debt Repaid | -3,952 | -2,580 | -2,352 | -2,320 | -2,601 | -4,338 | Upgrade
|
| Net Debt Issued (Repaid) | -302.04 | 571.51 | 815.96 | 373.41 | -772.86 | -592.54 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,533 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -177.43 | -75.24 | -245.91 | -109.91 | Upgrade
|
| Common Dividends Paid | -783.59 | -681.55 | -990.89 | -768.66 | -635.65 | -587.04 | Upgrade
|
| Other Financing Activities | -85.37 | 27.68 | -132.86 | 177.57 | 534.17 | 392.09 | Upgrade
|
| Financing Cash Flow | -1,171 | -82.36 | -485.22 | -292.92 | 412.75 | -897.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | -40.01 | -16.78 | 8.92 | -20.59 | 21.13 | -11.31 | Upgrade
|
| Net Cash Flow | -109.5 | 727.04 | -485.56 | -1,209 | 1,625 | 1,293 | Upgrade
|
| Free Cash Flow | 612.61 | 873.86 | 75.82 | 145.69 | 1,885 | 2,078 | Upgrade
|
| Free Cash Flow Growth | 67.42% | 1052.51% | -47.96% | -92.27% | -9.25% | 39.48% | Upgrade
|
| Free Cash Flow Margin | 9.54% | 13.48% | 1.24% | 1.83% | 17.77% | 19.49% | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.47 | 0.04 | 0.08 | 1.04 | 1.15 | Upgrade
|
| Cash Income Tax Paid | 595.02 | 614.84 | 775.28 | 970.56 | 962.96 | 725.21 | Upgrade
|
| Levered Free Cash Flow | 70.64 | -131.97 | 36.41 | -338.09 | 1,603 | 1,479 | Upgrade
|
| Unlevered Free Cash Flow | 245.19 | -21.57 | 149.53 | -231.43 | 1,721 | 1,622 | Upgrade
|
| Change in Working Capital | -560.65 | -560.65 | -716.06 | -1,293 | -356.6 | 142.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.